UniProt ID | COF1_HUMAN | |
---|---|---|
UniProt AC | P23528 | |
Protein Name | Cofilin-1 | |
Gene Name | CFL1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 166 | |
Subcellular Localization |
Nucleus matrix . Cytoplasm, cytoskeleton . Cell projection, ruffle membrane Peripheral membrane protein Cytoplasmic side . Cell projection, lamellipodium membrane Peripheral membrane protein Cytoplasmic side . Cell projection, lamellipodium . Note |
|
Protein Description | Binds to F-actin and exhibits pH-sensitive F-actin depolymerizing activity. Regulates actin cytoskeleton dynamics. Important for normal progress through mitosis and normal cytokinesis. Plays a role in the regulation of cell morphology and cytoskeletal organization. Required for the up-regulation of atypical chemokine receptor ACKR2 from endosomal compartment to cell membrane, increasing its efficiency in chemokine uptake and degradation. [PubMed: 11812157] | |
Protein Sequence | MASGVAVSDGVIKVFNDMKVRKSSTPEEVKKRKKAVLFCLSEDKKNIILEEGKEILVGDVGQTVDDPYATFVKMLPDKDCRYALYDATYETKESKKEDLVFIFWAPESAPLKSKMIYASSKDAIKKKLTGIKHELQANCYEEVKDRCTLAEKLGGSAVISLEGKPL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MASGVAVSD ------CCCCEEECC | 18.26 | 20068231 | |
3 | Phosphorylation | -----MASGVAVSDG -----CCCCEEECCC | 32.28 | 29255136 | |
8 | O-linked_Glycosylation | MASGVAVSDGVIKVF CCCCEEECCCEEEEE | 20.93 | 23301498 | |
8 | Phosphorylation | MASGVAVSDGVIKVF CCCCEEECCCEEEEE | 20.93 | 30266825 | |
13 | Sumoylation | AVSDGVIKVFNDMKV EECCCEEEEECCCCC | 38.07 | - | |
13 | Acetylation | AVSDGVIKVFNDMKV EECCCEEEEECCCCC | 38.07 | 19608861 | |
13 | Sumoylation | AVSDGVIKVFNDMKV EECCCEEEEECCCCC | 38.07 | 19608861 | |
13 | Ubiquitination | AVSDGVIKVFNDMKV EECCCEEEEECCCCC | 38.07 | 21890473 | |
19 | Sumoylation | IKVFNDMKVRKSSTP EEEECCCCCCCCCCH | 41.57 | - | |
19 | 2-Hydroxyisobutyrylation | IKVFNDMKVRKSSTP EEEECCCCCCCCCCH | 41.57 | - | |
19 | Acetylation | IKVFNDMKVRKSSTP EEEECCCCCCCCCCH | 41.57 | 25825284 | |
19 | Malonylation | IKVFNDMKVRKSSTP EEEECCCCCCCCCCH | 41.57 | 26320211 | |
19 | Methylation | IKVFNDMKVRKSSTP EEEECCCCCCCCCCH | 41.57 | 19608861 | |
19 | Sumoylation | IKVFNDMKVRKSSTP EEEECCCCCCCCCCH | 41.57 | 19608861 | |
19 | Ubiquitination | IKVFNDMKVRKSSTP EEEECCCCCCCCCCH | 41.57 | 21890473 | |
22 | Acetylation | FNDMKVRKSSTPEEV ECCCCCCCCCCHHHH | 52.31 | 27178108 | |
22 | Ubiquitination | FNDMKVRKSSTPEEV ECCCCCCCCCCHHHH | 52.31 | - | |
23 | Phosphorylation | NDMKVRKSSTPEEVK CCCCCCCCCCHHHHH | 28.96 | 30278072 | |
24 | Phosphorylation | DMKVRKSSTPEEVKK CCCCCCCCCHHHHHH | 51.52 | 29255136 | |
25 | Phosphorylation | MKVRKSSTPEEVKKR CCCCCCCCHHHHHHH | 41.64 | 29255136 | |
30 | Sumoylation | SSTPEEVKKRKKAVL CCCHHHHHHHHCEEE | 50.57 | - | |
30 | 2-Hydroxyisobutyrylation | SSTPEEVKKRKKAVL CCCHHHHHHHHCEEE | 50.57 | - | |
30 | Acetylation | SSTPEEVKKRKKAVL CCCHHHHHHHHCEEE | 50.57 | 21339330 | |
30 | Sumoylation | SSTPEEVKKRKKAVL CCCHHHHHHHHCEEE | 50.57 | - | |
30 | Ubiquitination | SSTPEEVKKRKKAVL CCCHHHHHHHHCEEE | 50.57 | - | |
31 | Acetylation | STPEEVKKRKKAVLF CCHHHHHHHHCEEEE | 74.71 | 11923949 | |
33 | Acetylation | PEEVKKRKKAVLFCL HHHHHHHHCEEEEEC | 54.70 | 7616599 | |
33 | Ubiquitination | PEEVKKRKKAVLFCL HHHHHHHHCEEEEEC | 54.70 | - | |
34 | Sumoylation | EEVKKRKKAVLFCLS HHHHHHHCEEEEECC | 48.00 | - | |
34 | 2-Hydroxyisobutyrylation | EEVKKRKKAVLFCLS HHHHHHHCEEEEECC | 48.00 | - | |
34 | Acetylation | EEVKKRKKAVLFCLS HHHHHHHCEEEEECC | 48.00 | 26051181 | |
34 | Sumoylation | EEVKKRKKAVLFCLS HHHHHHHCEEEEECC | 48.00 | - | |
34 | Ubiquitination | EEVKKRKKAVLFCLS HHHHHHHCEEEEECC | 48.00 | - | |
39 | Glutathionylation | RKKAVLFCLSEDKKN HHCEEEEECCCCCCE | 3.41 | 22555962 | |
39 | S-nitrosylation | RKKAVLFCLSEDKKN HHCEEEEECCCCCCE | 3.41 | 24105792 | |
39 | S-palmitoylation | RKKAVLFCLSEDKKN HHCEEEEECCCCCCE | 3.41 | 29575903 | |
41 | Phosphorylation | KAVLFCLSEDKKNII CEEEEECCCCCCEEE | 44.95 | 23401153 | |
44 | Sumoylation | LFCLSEDKKNIILEE EEECCCCCCEEEECC | 43.60 | - | |
44 | Acetylation | LFCLSEDKKNIILEE EEECCCCCCEEEECC | 43.60 | 23954790 | |
44 | Malonylation | LFCLSEDKKNIILEE EEECCCCCCEEEECC | 43.60 | 26320211 | |
44 | Sumoylation | LFCLSEDKKNIILEE EEECCCCCCEEEECC | 43.60 | - | |
44 | Ubiquitination | LFCLSEDKKNIILEE EEECCCCCCEEEECC | 43.60 | - | |
45 | Sumoylation | FCLSEDKKNIILEEG EECCCCCCEEEECCC | 66.74 | - | |
45 | Acetylation | FCLSEDKKNIILEEG EECCCCCCEEEECCC | 66.74 | 27452117 | |
45 | Malonylation | FCLSEDKKNIILEEG EECCCCCCEEEECCC | 66.74 | 26320211 | |
45 | Sumoylation | FCLSEDKKNIILEEG EECCCCCCEEEECCC | 66.74 | - | |
45 | Ubiquitination | FCLSEDKKNIILEEG EECCCCCCEEEECCC | 66.74 | - | |
53 | Sumoylation | NIILEEGKEILVGDV EEEECCCCEEEECCC | 44.88 | - | |
53 | Acetylation | NIILEEGKEILVGDV EEEECCCCEEEECCC | 44.88 | 26822725 | |
53 | Sumoylation | NIILEEGKEILVGDV EEEECCCCEEEECCC | 44.88 | - | |
53 | Ubiquitination | NIILEEGKEILVGDV EEEECCCCEEEECCC | 44.88 | 21906983 | |
63 | Phosphorylation | LVGDVGQTVDDPYAT EECCCCCCCCCCHHH | 21.70 | 28450419 | |
68 | Nitration | GQTVDDPYATFVKML CCCCCCCHHHHHCCC | 25.85 | - | |
68 | Phosphorylation | GQTVDDPYATFVKML CCCCCCCHHHHHCCC | 25.85 | 27273156 | |
70 | Phosphorylation | TVDDPYATFVKMLPD CCCCCHHHHHCCCCC | 24.10 | 25159151 | |
73 | Acetylation | DPYATFVKMLPDKDC CCHHHHHCCCCCCCC | 30.45 | 19608861 | |
73 | Sumoylation | DPYATFVKMLPDKDC CCHHHHHCCCCCCCC | 30.45 | 19608861 | |
73 | Ubiquitination | DPYATFVKMLPDKDC CCHHHHHCCCCCCCC | 30.45 | 73 | |
74 | Sulfoxidation | PYATFVKMLPDKDCR CHHHHHCCCCCCCCC | 5.73 | 30846556 | |
78 | Acetylation | FVKMLPDKDCRYALY HHCCCCCCCCCHHEE | 57.71 | 23749302 | |
78 | Malonylation | FVKMLPDKDCRYALY HHCCCCCCCCCHHEE | 57.71 | 26320211 | |
78 | Ubiquitination | FVKMLPDKDCRYALY HHCCCCCCCCCHHEE | 57.71 | - | |
80 | Glutathionylation | KMLPDKDCRYALYDA CCCCCCCCCHHEEEC | 4.40 | 22555962 | |
80 | S-nitrosylation | KMLPDKDCRYALYDA CCCCCCCCCHHEEEC | 4.40 | 24105792 | |
82 | Phosphorylation | LPDKDCRYALYDATY CCCCCCCHHEEECCC | 13.80 | 30550596 | |
85 | Phosphorylation | KDCRYALYDATYETK CCCCHHEEECCCCCC | 8.72 | 27273156 | |
88 | Phosphorylation | RYALYDATYETKESK CHHEEECCCCCCCCC | 20.99 | 27273156 | |
89 | Phosphorylation | YALYDATYETKESKK HHEEECCCCCCCCCC | 24.26 | 25159151 | |
91 | Phosphorylation | LYDATYETKESKKED EEECCCCCCCCCCCC | 29.69 | 27273156 | |
92 | 2-Hydroxyisobutyrylation | YDATYETKESKKEDL EECCCCCCCCCCCCE | 48.31 | - | |
92 | Acetylation | YDATYETKESKKEDL EECCCCCCCCCCCCE | 48.31 | 23954790 | |
92 | Malonylation | YDATYETKESKKEDL EECCCCCCCCCCCCE | 48.31 | 26320211 | |
92 | Ubiquitination | YDATYETKESKKEDL EECCCCCCCCCCCCE | 48.31 | 19608861 | |
94 | Phosphorylation | ATYETKESKKEDLVF CCCCCCCCCCCCEEE | 51.05 | 26356563 | |
95 | Ubiquitination | TYETKESKKEDLVFI CCCCCCCCCCCEEEE | 62.36 | - | |
96 | Trimethylation | YETKESKKEDLVFIF CCCCCCCCCCEEEEE | 66.78 | - | |
96 | 2-Hydroxyisobutyrylation | YETKESKKEDLVFIF CCCCCCCCCCEEEEE | 66.78 | - | |
96 | Acetylation | YETKESKKEDLVFIF CCCCCCCCCCEEEEE | 66.78 | 129419 | |
96 | Methylation | YETKESKKEDLVFIF CCCCCCCCCCEEEEE | 66.78 | - | |
96 | Ubiquitination | YETKESKKEDLVFIF CCCCCCCCCCEEEEE | 66.78 | 21890473 | |
108 | O-linked_Glycosylation | FIFWAPESAPLKSKM EEEECCCCCCCCCCE | 33.84 | 23301498 | |
108 | Phosphorylation | FIFWAPESAPLKSKM EEEECCCCCCCCCCE | 33.84 | 28450419 | |
112 | Sumoylation | APESAPLKSKMIYAS CCCCCCCCCCEEEEC | 47.15 | - | |
112 | 2-Hydroxyisobutyrylation | APESAPLKSKMIYAS CCCCCCCCCCEEEEC | 47.15 | - | |
112 | Acetylation | APESAPLKSKMIYAS CCCCCCCCCCEEEEC | 47.15 | 25953088 | |
112 | Sumoylation | APESAPLKSKMIYAS CCCCCCCCCCEEEEC | 47.15 | - | |
112 | Ubiquitination | APESAPLKSKMIYAS CCCCCCCCCCEEEEC | 47.15 | 21906983 | |
113 | Phosphorylation | PESAPLKSKMIYASS CCCCCCCCCEEEECC | 34.83 | 28270605 | |
114 | Sumoylation | ESAPLKSKMIYASSK CCCCCCCCEEEECCH | 27.94 | - | |
114 | 2-Hydroxyisobutyrylation | ESAPLKSKMIYASSK CCCCCCCCEEEECCH | 27.94 | - | |
114 | Acetylation | ESAPLKSKMIYASSK CCCCCCCCEEEECCH | 27.94 | 19608861 | |
114 | Methylation | ESAPLKSKMIYASSK CCCCCCCCEEEECCH | 27.94 | 24129315 | |
114 | Succinylation | ESAPLKSKMIYASSK CCCCCCCCEEEECCH | 27.94 | 23954790 | |
114 | Sumoylation | ESAPLKSKMIYASSK CCCCCCCCEEEECCH | 27.94 | 19608861 | |
114 | Ubiquitination | ESAPLKSKMIYASSK CCCCCCCCEEEECCH | 27.94 | 21890473 | |
115 | Sulfoxidation | SAPLKSKMIYASSKD CCCCCCCEEEECCHH | 3.50 | 25058340 | |
117 | Phosphorylation | PLKSKMIYASSKDAI CCCCCEEEECCHHHH | 9.27 | 27273156 | |
119 | Phosphorylation | KSKMIYASSKDAIKK CCCEEEECCHHHHHH | 22.43 | 26356563 | |
120 | Phosphorylation | SKMIYASSKDAIKKK CCEEEECCHHHHHHH | 26.78 | 26356563 | |
121 | Sumoylation | KMIYASSKDAIKKKL CEEEECCHHHHHHHH | 49.00 | - | |
121 | Acetylation | KMIYASSKDAIKKKL CEEEECCHHHHHHHH | 49.00 | 23954790 | |
121 | Malonylation | KMIYASSKDAIKKKL CEEEECCHHHHHHHH | 49.00 | 26320211 | |
121 | Sumoylation | KMIYASSKDAIKKKL CEEEECCHHHHHHHH | 49.00 | 19608861 | |
121 | Ubiquitination | KMIYASSKDAIKKKL CEEEECCHHHHHHHH | 49.00 | 19608861 | |
125 | Acetylation | ASSKDAIKKKLTGIK ECCHHHHHHHHHCCC | 45.64 | 8273235 | |
126 | Acetylation | SSKDAIKKKLTGIKH CCHHHHHHHHHCCCH | 47.07 | 70231 | |
127 | Acetylation | SKDAIKKKLTGIKHE CHHHHHHHHHCCCHH | 46.40 | 70235 | |
127 | Ubiquitination | SKDAIKKKLTGIKHE CHHHHHHHHHCCCHH | 46.40 | 21890473 | |
129 | Phosphorylation | DAIKKKLTGIKHELQ HHHHHHHHCCCHHHH | 45.82 | 29496963 | |
132 | Sumoylation | KKKLTGIKHELQANC HHHHHCCCHHHHHCH | 32.16 | - | |
132 | 2-Hydroxyisobutyrylation | KKKLTGIKHELQANC HHHHHCCCHHHHHCH | 32.16 | - | |
132 | Acetylation | KKKLTGIKHELQANC HHHHHCCCHHHHHCH | 32.16 | 16916647 | |
132 | Malonylation | KKKLTGIKHELQANC HHHHHCCCHHHHHCH | 32.16 | 26320211 | |
132 | Sumoylation | KKKLTGIKHELQANC HHHHHCCCHHHHHCH | 32.16 | 28112733 | |
132 | Ubiquitination | KKKLTGIKHELQANC HHHHHCCCHHHHHCH | 32.16 | - | |
139 | S-nitrosocysteine | KHELQANCYEEVKDR CHHHHHCHHHHHHHH | 5.19 | - | |
139 | Glutathionylation | KHELQANCYEEVKDR CHHHHHCHHHHHHHH | 5.19 | 22555962 | |
139 | S-nitrosylation | KHELQANCYEEVKDR CHHHHHCHHHHHHHH | 5.19 | 24105792 | |
140 | Nitration | HELQANCYEEVKDRC HHHHHCHHHHHHHHC | 18.22 | - | |
140 | Phosphorylation | HELQANCYEEVKDRC HHHHHCHHHHHHHHC | 18.22 | 25159151 | |
144 | 2-Hydroxyisobutyrylation | ANCYEEVKDRCTLAE HCHHHHHHHHCHHHH | 42.61 | - | |
144 | Acetylation | ANCYEEVKDRCTLAE HCHHHHHHHHCHHHH | 42.61 | 19608861 | |
144 | Malonylation | ANCYEEVKDRCTLAE HCHHHHHHHHCHHHH | 42.61 | 26320211 | |
144 | Ubiquitination | ANCYEEVKDRCTLAE HCHHHHHHHHCHHHH | 42.61 | 19608861 | |
147 | S-nitrosocysteine | YEEVKDRCTLAEKLG HHHHHHHCHHHHHHC | 5.40 | - | |
147 | S-nitrosylation | YEEVKDRCTLAEKLG HHHHHHHCHHHHHHC | 5.40 | 19483679 | |
148 | Phosphorylation | EEVKDRCTLAEKLGG HHHHHHCHHHHHHCC | 29.87 | 20068231 | |
152 | Acetylation | DRCTLAEKLGGSAVI HHCHHHHHHCCCEEE | 46.99 | 25953088 | |
152 | Ubiquitination | DRCTLAEKLGGSAVI HHCHHHHHHCCCEEE | 46.99 | - | |
156 | Phosphorylation | LAEKLGGSAVISLEG HHHHHCCCEEEEECC | 19.98 | 29255136 | |
160 | Phosphorylation | LGGSAVISLEGKPL- HCCCEEEEECCEEC- | 17.48 | 30266825 | |
164 | Sumoylation | AVISLEGKPL----- EEEEECCEEC----- | 33.50 | - | |
164 | Acetylation | AVISLEGKPL----- EEEEECCEEC----- | 33.50 | 25953088 | |
164 | Sumoylation | AVISLEGKPL----- EEEEECCEEC----- | 33.50 | - | |
164 | Ubiquitination | AVISLEGKPL----- EEEEECCEEC----- | 33.50 | 21906983 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
3 | S | Phosphorylation | Kinase | PRKD1 | Q15139 | PSP |
3 | S | Phosphorylation | Kinase | LIMK1 | P53667 | PSP |
3 | S | Phosphorylation | Kinase | LIMK1 | P53669 | PSP |
3 | S | Phosphorylation | Kinase | LIMK2 | P53671 | PSP |
3 | S | Phosphorylation | Kinase | NRK | Q7Z2Y5 | Uniprot |
3 | S | Phosphorylation | Kinase | ROCK2 | P70336 | PSP |
3 | S | Phosphorylation | Kinase | TESK1 | Q15569 | PSP |
3 | S | Phosphorylation | Kinase | TESK1 | Q63572 | PSP |
3 | S | Phosphorylation | Kinase | TESK2 | Q96S53 | PhosphoELM |
23 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
24 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
68 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of COF1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-3, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-13; LYS-19; LYS-73 ANDLYS-144, AND MASS SPECTROMETRY. | |
"Substrate and functional diversity of lysine acetylation revealed bya proteomics survey."; Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.; Mol. Cell 23:607-618(2006). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-132, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3; TYR-68 AND SER-156,AND MASS SPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-3, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3; SER-41 AND SER-156,AND MASS SPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-156, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3 AND THR-25, AND MASSSPECTROMETRY. | |
"Cofilin phosphorylation and actin polymerization by NRK/NESK, amember of the germinal center kinase family."; Nakano K., Kanai-Azuma M., Kanai Y., Moriyama K., Yazaki K.,Hayashi Y., Kitamura N.; Exp. Cell Res. 287:219-227(2003). Cited for: PHOSPHORYLATION AT SER-3 BY NRK. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-89 AND TYR-140, AND MASSSPECTROMETRY. | |
"Multiple reaction monitoring for robust quantitative proteomicanalysis of cellular signaling networks."; Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.; Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-140, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-140, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-140, AND MASSSPECTROMETRY. |